Non-systemic treatment of metastatic kidney cancer: systematic review and a case report
Frontiers in Oncology · 12.12.2025 · 15
DOI: 10.3389/fonc.2025.1627467 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 12.12.2025. Verfasst von Gabija O Morkunaite und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objectives To date, there is insufficient literature on the local treatment options for metastatic renal cell carcinoma (mRCC). Various options, such as metastasectomy, thermal ablation, and stereotactic body radiotherapy, have gained attention for their potential to improve survival and quality of life in selected patients’ groups. This systematic review analyzes the effectiveness of these approaches and highlights their potential to improve survival outcomes. By analyzing survival outcomes, this review aims to guide future research, thereby enhancing clinical decision-making. Materials and methods A systematic review of studies published since 2009 was conducted, following PRISMA guidelines. Relevant articles were identified from PubMed and ScienceDirect databases, using search terms related to mRCC and non-systemic treatment. The review was not registered, and a protocol was not prepared. Additionally, a case report documenting the successful use of cryoablation in controlling metastases of kidney cancer was included to illustrate clinical relevance.
Results
Thirteen studies met the inclusion criteria. Complete metastasectomy demonstrated improved overall survival (OS) and progression-free survival (PFS) compared to incomplete or no metastasectomy. Stereotactic body radiotherapy (SBRT) and other forms of radiotherapy provided effective palliation and durable disease control.
Conclusions
This systematic review highlights the potential survival benefits for mRCC patients with the use of different local treatment modalities, especially in terms of complete metastasectomy. The findings show the need for continued research to optimize local treatment strategies, along with improving the quality of life for metastatic kidney cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
- Life Sciences Centre, Vilnius University, Vilnius, Lithuania.
- Centre of Clinical Research, National Cancer Institute, Vilnius, Lithuania.
- Centre of Orthopedics and Traumatology, Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Clinic of Rheumatology, Orthopaedic Traumatology and Reconstructive Surgery, Vilnius University Hospital,…
- Laboratory of Cancer Epidemiology, National Cancer Institute, Vilnius, Lithuania.
- Faculty of Medicine, Institute of Health Sciences, Vilnius University, Vilnius, Lithuania.
Zitieren
APA
Morkunaite, G. O., Mickeviciute, U., Trakymas, M., Kincius, M., Urbonas, V., Kvederas, G., & Patasius, A. (2025). Non-systemic treatment of metastatic kidney cancer: systematic review and a case report. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1627467
Vancouver
Morkunaite GO, Mickeviciute U, Trakymas M, Kincius M, Urbonas V, Kvederas G, et al. Non-systemic treatment of metastatic kidney cancer: systematic review and a case report. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1627467
BibTeX
@article{Morkunaite2025,
author = {Morkunaite, Gabija O and Mickeviciute, Ugne and Trakymas, Mantas and Kincius, Marius and Urbonas, Vincas and Kvederas, Giedrius and Patasius, Ausvydas},
title = {Non-systemic treatment of metastatic kidney cancer: systematic review and a case report},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1627467}
}
EUVIMED